Physician profile
Nelson Lee
NPI 1821472630
$6,958.84
in general payments reported to CMS, 2019-2025
42 companies · $1,476 in 2025
The $1,476 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,141 · 2020: $519 · 2021: $771 · 2022: $808 · 2023: $992 · 2024: $1,252 · 2025: $1,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,719.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,681.65 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $996.29 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $361.99 | 2019-2024 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $340.96 | 2021-2025 | Jardiance |
| Exact Sciences Corporation | $315.96 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $300.26 | 2021-2025 | |
| Pfizer INC. | $207.91 | 2019-2025 | |
| Amarin Pharma, INC. | $204.02 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $156.24 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Merck Sharp & Dohme LLC | $114.11 | 2019-2025 | Capvaxive, Gardasil 9 |
| Astellas Pharma US INC | $111.37 | 2019-2025 | Veozah |
| Phathom Pharmaceuticals, INC. | $92.76 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $90.03 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $87.09 | 2019-2023 | |
| Amgen INC. | $83.64 | 2021-2023 | Repatha, Otezla |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.